|Product Description||NDC||Lot #||Expiration Date|
|Vistide ® (cidofovir injection)||61958-0101-1||B120217A||May 2015|
Donald Trump's presidency could result in a more than $500 billion windfall for Fortune 500 companies should he get his way on tax reform.
Jim Cramer likes Harley and Enterprise Products Partners, but says stay away from Costamare and Achaogen.
Jim Cramer explains how bullish comments from one semiconductor equipment maker lifts shares throughout the sector.
If you buy right, time and value should do most of the heavy lifting for you.